| Stage | MTZ | % of rev | DY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.2B | 100.00% | $2.0B | 100.00% | MTZ ×2.57 |
| Gross profit | $661M | 12.83% | $441M | 21.96% | DY +9.1pp |
| Operating income | $275M | 5.35% | $192M | 9.57% | DY +4.2pp |
| Pre-tax income | $220M | 4.27% | $154M | 7.68% | DY +3.4pp |
| Net income | $168M | 3.26% | $116M | 5.76% | DY +2.5pp |
| Stage | MTZ | DY | Gap · A − B |
|---|---|---|---|
| Revenue | $5.2B100.00% | $2.0B100.00% | MTZ ×2.57 |
| Gross profit | 12.83%$661M | 21.96%$441M | DY +9.1pp |
| Operating income | 5.35%$275M | 9.57%$192M | DY +4.2pp |
| Pre-tax income | 4.27%$220M | 7.68%$154M | DY +3.4pp |
| Net income |
| 3.26%$168M |
| 5.76%$116M |
| DY +2.5pp |
None
No disclosed counterparties: MTZ.